Join the club for FREE to access the whole archive and other member benefits.

Shmuel Ben-Sasson

Chief Technology Officer at Vitalunga, Senior Scientist at The Hebrew University of Jerusalem

Author of more than 90 scholarly articles in peer reviewed journals and the principal inventor of more than 20 granted patents. Among his significant scientific contributions is the invention and development of the TUNEL assay, now serving as the universal gold-standard for the in-situ identification of apoptosis.

Visit website: https://medicine.ekmd.huji.ac.il/en/research/mulib/Pages/default.aspx

 shmuel-ben-sasson-821a51201

See also: Academia The Hebrew University of Jerusalem - University in Jerusalem.

Details last updated 16-Aug-2022

Shmuel Ben-Sasson News

Mitophagy activators shown to increase lifespan and healthspan in C.elegans

Mitophagy activators shown to increase lifespan and healthspan in C.elegans

Longevity Technology - 10-Aug-2022

Vitalunga to usher the novel drug for hepatocellular carcinoma clinical trials